
Indoco Remedies Limited has informed the Exchange regarding a press release dated October 30, 2024, titled "Indoco Remedies receives final ANDA approval from USFDA forVarenicline Tablets, 0.5 mg and 1 mg".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated October 30, 2024, titled "Indoco Remedies receives final ANDA approval from USFDA forVarenicline Tablets, 0.5 mg and 1 mg".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies